Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Roivant Sciences Cash Provided by (Used in) Operating Activity, Including Discontinued Operation increased by 16.6% to -$163.82M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.1%, from -$172.57M to -$163.82M. Over 4 years (FY 2021 to FY 2025), Cash Provided by (Used in) Operating Activity, Including Discontinued Operation shows a downward trend with a 2.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
A comprehensive measure of the company's total cash generation efficiency.
Detailed definition
The consolidated net cash flow from operating activities, including both continuing and discontinued operations. It prov...
Peer comparison
Standard consolidated cash flow metric used by all global enterprises.
other_net_cash_provided_by_used_in_operating_activitiesHistorical Data
| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$141.17M | -$120.60M | -$268.49M | -$147.47M | -$252.08M | -$189.63M | -$222.59M | -$179.09M | -$249.93M | -$196.43M | -$210.45M | -$108.46M | -$192.83M | -$266.81M | -$207.25M | -$172.57M | -$204.38M | -$185.66M | -$196.48M | -$163.82M |
| QoQ Change | — | +14.6% | -122.6% | +45.1% | -70.9% | +24.8% | -17.4% | +19.5% | -39.6% | +21.4% | -7.1% | +48.5% | -77.8% | -38.4% | +22.3% | +16.7% | -18.4% | +9.2% | -5.8% | +16.6% |
| YoY Change | — | — | — | — | -78.6% | -57.2% | +17.1% | -21.4% | +0.9% | -3.6% | +5.5% | +39.4% | +22.8% | -35.8% | +1.5% | -59.1% | -6.0% | +30.4% | +5.2% | +5.1% |
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's cash provided by (used in) operating activity, including discontinued operation?
- Roivant Sciences (ROIV) reported cash provided by (used in) operating activity, including discontinued operation of -$163.82M in Q1 2026.
- How has Roivant Sciences's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- Roivant Sciences's cash provided by (used in) operating activity, including discontinued operation increased by 5.1% year-over-year, from -$172.57M to -$163.82M.
- What is the long-term trend for Roivant Sciences's cash provided by (used in) operating activity, including discontinued operation?
- Over 4 years (2021 to 2025), Roivant Sciences's cash provided by (used in) operating activity, including discontinued operation has grown at a 2.6% compound annual growth rate (CAGR), from -$677.73M to -$750.35M.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Total net cash flow from all operating activities, including discontinued units.